Our Company

Central Garden & Pet Company ("Central") is a market leader in the garden and
pet industries in the United States. For over 40 years, Central has proudly
nurtured happy and healthy homes by bringing innovative and trusted solutions to
consumers and its customers. We manage our operations through two reportable
segments: Pet and Garden.

Our pet segment includes dog and cat supplies such as dog treats and chews,
toys, pet beds and grooming products, waste management and training pads, pet
containment, supplies for aquatics, small animals, reptiles and pet birds
including toys, cages and habitats, bedding, food and supplements, products for
equine and livestock, animal and household health and insect control products,
live fish and small animals as well as outdoor cushions. These products are sold
under brands such as Aqueon®, Cadet®, Comfort Zone®, Farnam®, Four Paws®, K&H
Pet Products® ("K&H"), Kaytee®, Nylabone® and Zilla®.

Our garden segment includes lawn and garden consumables such as grass,
vegetable, flower and herb seed, wild bird feed, bird houses and other birding
accessories, weed, grass, and other herbicides, insecticide and pesticide
products, fertilizers and live plants. These products are sold under brands such
as Amdro®, Ferry-Morse®, Pennington® and Sevin®.

In fiscal 2021, our consolidated net sales were $3.3 billion, of which our Pet
segment, or Pet, accounted for approximately $1.9 billion and our Garden
segment, or Garden, accounted for approximately $1.4 billion. In fiscal 2021,
our operating income was $254 million consisting of income from our Pet segment
of $208 million, income from our Garden segment of $139 million and corporate
expenses of $93 million.

We were incorporated in Delaware in May 1992 as the successor to a California
corporation that was formed in 1955. Our executive offices are located at 1340
Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone
number is (925) 948-4000. Our website is www.central.com. The information on our
website is not incorporated by reference in this quarterly report.


                                       23
--------------------------------------------------------------------------------

Recent Developments

Fiscal 2022 Second Quarter Financial Performance:



•Net sales increased $19.1 million, or 2.0%, from the prior year quarter to
$954.4 million. Pet segment sales increased $5.7 million, and Garden segment
sales increased $13.4 million.

•Organic net sales declined 3.5%, comprised of an 8.7% decrease in our Garden segment partially offset by a 1.2% increase in our Pet segment.

•Gross profit increased $14.4 million from the prior year quarter, and gross margin increased 100 basis points to 30.1%.



•Selling, general and administrative expense increased $12.2 million from the
prior year quarter to $179.9 million and as a percentage of net sales increased
100 basis points to 18.9%.

•Operating income increased $2.2 million, or 2.1%, from the prior year quarter, to $106.8 million.



•Net income in the second quarter of fiscal 2022 was $69.7 million, or $1.27 per
diluted share, compared to net income of $73.0 million, or $1.32 per diluted
share, in the second quarter of fiscal 2021.

COVID-19 Impact

COVID-19 has led to adverse impacts on human health, the global economy and society at large. From the beginning, our priority has been the safety of our employees, customers and consumers.



Central has been impacted by COVID-19 in a number of ways, including increased
demand and sales. The increased demand for our products continues to challenge
our supply chain and our ability to procure and manufacture enough product to
meet the continued high levels of demand. At some of our facilities, we have
experienced reduced productivity and increased employee absences, which we
expect to continue during the balance of the pandemic. Our manufacturing
facilities and distribution centers are currently open and operational. We have
incurred and will continue to incur additional costs including personal
protective equipment and sanitation costs. We have hosted mobile vaccination
clinics at some of our larger manufacturing and distribution sites, in order to
make vaccines available to our employees.

The pandemic and related increase in demand have created operational challenges,
which have impacted our service and fill rates. While they have improved in
fiscal 2022, they have yet to return to our historical rates. Our supply chain
has experienced disruptions and delays which have resulted in increased
operational and logistics costs. We may also experience additional disruptions
in our supply chain as the pandemic continues, although we cannot reasonably
estimate the potential impact or timing of those events, and we may not be able
to mitigate such impact. We continue to face supply constraints for commodities,
materials and freight and the limited availability of labor. Inflationary
pressures stemming in part from the COVID-19 operating environment are
continuing to result in significant increases in costs for commodities,
materials, labor and freight.

We believe we have sufficient liquidity to satisfy our cash needs with our cash and revolving credit facility as we manage through the current economic and health environment.



While vaccination efforts and the easing of government restrictions have
signaled an improving health environment, the timing of a full recovery remains
uncertain. Forecasting and planning remain challenging in the current
environment and will continue to be challenging as the pandemic eases in the
future. In the current uncertain environment, our employees, customers and
consumers will continue to be our priority as we manage our business to deliver
long-term growth.


Results of Operations

                       Three Months Ended March 26, 2022
                Compared with Three Months Ended March 27, 2021

Net Sales

Net sales for the three months ended March 26, 2022 increased $19.1 million, or
2.0%, to $954.4 million from $935.3 million for the three months ended March 27,
2021. Organic net sales, which exclude the impact of acquisitions and
divestitures in the last 12 months, decreased $32.7 million, or 3.5%, as
compared to the fiscal 2021 quarter. Our branded product sales increased $29.2
million, and sales of other manufacturers' products decreased $10.1 million.
                                       24
--------------------------------------------------------------------------------

Pet net sales increased $5.7 million, or 1.2%, to $497.7 million for the three
months ended March 26, 2022 from $492.0 million for the three months ended March
27, 2021. This organic sales increase was due primarily to pricing actions taken
to offset the current inflationary operating environment. Increases in net sales
in our dog and cat treats and toy business and our outdoor cushion business were
partially offset by lower sales in our dog bed business. The increase in sales
in our dog and cat treats and toy business was due to pricing actions taken to
offset inflationary pressures; and the increase in our outdoor cushion business
was due primarily to a volume shift from our first quarter to our second
quarter. The decrease in our dog bed business was due to a purposeful SKU
rationalization. Pet branded product sales increased $6.3 million while sales of
other manufacturers' products declined $0.6 million.

Garden net sales increased $13.4 million, or 3.0%, to $456.7 million for the
three months ended March 26, 2022 from $443.3 million for the three months ended
March 27, 2021. The sales increase was due to the addition of our fiscal 2021
acquisitions. Organic sales decreased 8.7% due primarily to unfavorable weather
resulting in a delayed start to the garden season which more than offset
increases from pricing actions taken to offset rising costs. As such, most of
our garden businesses had decreased sales in the quarter with the exception of
wild bird feed resulting from price increases taken to offset large commodity
inflation. Garden branded sales increased $22.9 million due to our fiscal 2021
acquisitions while sales of other manufacturers' products decreased $9.5
million.

Gross Profit



Gross profit for the three months ended March 26, 2022 increased $14.4 million,
or 5.3%, to $286.8 million from $272.4 million for the three months ended March
27, 2021. Gross margin increased 100 basis points to 30.1% for the three months
ended March 26, 2022 from 29.1% for the three months ended March 27, 2021. Both
operating segments contributed to the increase in gross profit and gross margin.
The increases in gross profit and gross margin were driven by pricing actions
and the impact of our fiscal 2021 acquisitions partially offset by significant
cost inflation in commodities, labor, and freight. Overall, our gross margins
continue to be under pressure from the current inflationary environment and we
continue to experience cost increases, primarily in commodities, labor and
freight. We intend to continue to seek price increases to help offset the rising
costs but do not anticipate that we will be able to fully offset the cost
pressures in fiscal 2022.

The improvement in the Pet segment was due to price increases and a more
favorable product mix which were only partially offset by cost inflation in
commodities, labor and freight. The improvement in our Garden segment was due
primarily to price increases that helped offset lower sales volumes due to the
late start to the garden season and to the impact of our fiscal 2021
acquisitions.

Selling, General and Administrative Expenses



Selling, general and administrative expenses increased $12.2 million, or 7.2%,
to $179.9 million for the three months ended March 26, 2022. As a percentage of
net sales, selling, general and administrative expenses increased to 18.9% for
the three months ended March 26, 2022, compared to 17.9% in the comparable prior
year quarter. Both operating segments and corporate had increased selling,
general and administrative expenses. Overall, the increases were due primarily
to the incremental expense from recent acquisitions, wage and freight inflation
and increased marketing investment for brand development and innovation.

Selling and delivery expense increased $4.3 million to $87.3 million for the
three months ended March 26, 2022. The increase was due primarily to our recent
acquisitions, wage and freight inflation and increased marketing investment for
brand development and innovation.

Warehouse and administrative expense increased $7.9 million, or 9.3%, to $92.6
million for the three months ended March 26, 2022. The increase was due
primarily to the warehouse and administrative costs associated with our four
fiscal 2021 acquisitions. Additionally, both operating segments experienced
increased labor and payroll-related expense. Corporate expenses increased $0.9
million due primarily to increased salary and wages from headcount additions and
equity compensation costs. Corporate expenses are included within administrative
expense and relate to the costs of unallocated executive, administrative,
finance, legal, human resources, and information technology functions.

Operating Income



Operating income increased $2.2 million, or 2.1%, to $106.8 million for the
three months ended March 26, 2022. The increase in operating income was due to
increased sales and gross profit partially offset by higher selling, general and
administrative expense. Our operating margin remained flat at 11.2% as compared
to the prior year quarter, as a 100 basis point increase in gross margin was
offset by a 100 basis point increase in selling, general and administrative
expense as a percentage of net sales.

Pet operating income decreased $1.4 million, or 2.3%, to $60.6 million for the
three months ended March 26, 2022. Pet operating income decreased due to higher
selling, general and administrative expense which more than offset the favorable
impact of increased sales and gross profit. Pet operating margin decreased 40
basis points to 12.2% due to higher input costs in the current inflationary
environment and increased marketing and brand building spend.

Garden operating income increased $4.5 million to $70.5 million for the three
months ended March 26, 2022 from $66.0 million for the three months ended March
27, 2021. Garden operating income increased due to increased sales and gross
profit partially offset by higher selling, general and administrative expense.
Garden operating margin increased 50 basis points to 15.4% due primarily to
increased prices and the favorable impact of our recent acquisitions.
                                       25
--------------------------------------------------------------------------------

Corporate expense increased $0.9 million, or 3.8%, to $24.3 million for the
three months ended March 26, 2022 from $23.4 million for the three months ended
March 27, 2021. Corporate expense increased due primarily to increased salaries
and wages from headcount additions and equity compensation costs.

Net Interest Expense



Net interest expense for the three months ended March 26, 2022 increased $4.6
million, or 44.8%, to $14.7 million due primarily to a higher debt balance
outstanding during the quarter. In April 2021, we issued $400 million aggregate
principal amount of 4.125% senior notes due April 2031. Debt outstanding on
March 26, 2022 was $1,185.8 million compared to $979.0 million at March 27,
2021.

Other Income (Expense)



Other income (expense) is comprised of income or losses from investments
accounted for under the equity method of accounting and foreign currency
exchange gains and losses. Other income (expense) was $0.4 million of expense
for the quarter ended March 26, 2022 compared to income of $0.7 million for the
quarter ended March 27, 2021, due primarily to foreign currency losses in the
current year quarter as compared to gains in the prior year quarter.

Income Taxes



Our effective income tax rate was 23.4% for the quarter ended March 26, 2022 and
22.7% for the quarter ended March 27, 2021. The increase in our effective income
tax rate was due primarily to increased foreign earnings in higher tax rate
jurisdictions.

Net Income and Earnings Per Share

Our net income in the second quarter of fiscal 2022 was $69.7 million, or $1.27 per diluted share, compared to a net income of $73.0 million, or $1.32 per diluted share, in the second quarter of fiscal 2021.




                        Six Months Ended March 26, 2022
                 Compared with Six Months Ended March 27, 2021
Net Sales

Net sales for the six months ended March 26, 2022 increased $88.3 million, or
5.8%, to $1,615.8 million from $1,527.5 million for the six months ended March
27, 2021. Organic net sales declined $29.6 million, or 1.9%, as compared to the
prior year six-month period. Our branded product sales increased $87.2 million,
and sales of other manufacturers' products increased $1.1 million.

Pet net sales increased $5.3 million, or 0.6%, to $933.7 million for the six
months ended March 26, 2022 from $928.4 million for the six months ended March
27, 2021. Net sales in the prior year period include sales from the Breeder's
Choice business unit, which we sold in December 2020. Organic net sales
increased $9.2 million, or 1.0%, as compared to the prior year six-month period.
The organic sales improvement was driven by price and volume based sales
increases in our dog and cat treats and toy business, animal health business and
outdoor cushion business, partially offset by a volume based sales decrease in
our dog bed business due primarily to SKU rationalization. Pet branded sales
increased $0.1 million, and sales of other manufacturer's products increased
$5.2 million.

Garden net sales increased $83.0 million, or 13.9%, to $682.1 million for the
six months ended March 26, 2022 from $599.1 million for the six months ended
March 27, 2021. Organic sales decreased $38.8 million, or 6.5%, while sales from
recent acquisitions contributed $121.8 million. The organic sales decrease was
due primarily to unfavorable weather causing a delayed start to the garden
season. As such, most of our garden businesses had decreased sales with the
exception of wild bird feed which benefited from price increases taken to offset
large commodity inflation. Garden branded sales increased $87.1 million, while
sales of other manufacturers' products decreased $4.1 million.

Gross Profit
Gross profit for the six months ended March 26, 2022 increased $47.2 million, or
10.8%, to $485.0 million from $437.8 million for the six months ended March 27,
2021. Gross margin improved 130 basis points to 30.0% for the six months ended
March 26, 2022 from 28.7% for the six months ended March 27, 2021. Both Pet and
Garden contributed to the increase in gross profit and gross margin. Both
segments are being impacted by the rapidly increasing cost environment. We have
implemented and intend to continue to seek price increases to help offset the
rising costs but do not anticipate we will be able to fully offset the cost
pressures in 2022. Although our gross margin increased in the current six-month
period, as compared to the prior year six month period, our operating margin
declined during the current six-month period.

                                       26
--------------------------------------------------------------------------------

In the Pet segment, the improved gross profit and margin were due primarily to
price increases taken to combat inflation and a favorable product mix partially
offset by increased commodity, freight and labor costs.
In the Garden segment, the improved gross profit and margin were due primarily
to price increases and the impact of our fiscal 2021 acquisitions, which
included the impact of purchase accounting in fiscal 2021 and the impact on our
product mix in the current year, partially offset by increased commodity,
freight and labor costs.

Selling, General and Administrative Expenses



Selling, general and administrative expenses increased $45.7 million, or 14.9%,
to $351.9 million for the six months ended March 26, 2022 from $306.2 million
for the six months ended March 27, 2021. As a percentage of net sales, selling,
general and administrative expenses increased to 21.8% for the six months ended
March 26, 2022 from 20.0% for the comparable prior year six-month period.

Selling and delivery expense increased $16.9 million, or 11.3%, to $166.4
million for the six months ended March 26, 2022 from $149.5 million for the six
months ended March 27, 2021. The increase was due primarily to the addition of
our fiscal 2021 acquisitions, marketing investment for brand development and
innovation.

Warehouse and administrative expense increased $28.8 million, or 18.4%, to
$185.5 million for the six months ended March 26, 2022 from $156.7 million for
the six months ended March 27, 2021. The increased expense was driven by the
addition of our four fiscal 2021 acquisitions in the Garden segment.
Additionally, both operating segments experienced increased labor, delivery,
fuel and rent rates due to the current inflationary environment. Corporate
expenses increased $4.9 million due primarily to increased payroll related
costs, non-cash equity compensation and medical insurance expense. Corporate
expenses are included within administrative expense and relate to the costs of
unallocated executive, administrative, finance, legal, human resources, and
information technology functions.

Operating Income



Operating income increased $1.4 million to $133.1 million for the six months
ended March 26, 2022 from $131.7 million for the six months ended March 27,
2021. Our operating margin decreased to 8.2% for the six months ended March 26,
2022 from 8.6% for the six months ended March 27, 2021. Increased sales and a
130 basis point improvement in gross margin was more than offset by a 180 basis
point increase in selling, general and administrative expense.

Pet operating income increased $0.3 million, or 0.3%, to $105.9 million for the
six months ended March 26, 2022 from $105.6 million for the six months ended
March 27, 2021. Pet operating income increased due to increased sales and gross
profit partially offset by higher selling, general and administrative expense.
Pet operating margin declined 10 basis points as an improved gross margin was
more than offset by higher selling, general and administrative expense as a
percentage of net sales.

Garden operating income increased $6.0 million to $76.6 million for the six
months ended March 26, 2022 from $70.6 million for the six months ended March
27, 2021. Garden operating income increased due to increased sales and gross
profit partially offset by higher selling, general and administrative expense.
Garden operating margin declined 60 basis points to 11.2% due to higher selling,
general and administrative expense as a percentage of net sales which more than
offset the favorable impact of increased sales and a higher gross margin.

Corporate operating expense increased $4.9 million to $49.4 million in the current nine-month period from $44.5 million in the comparable fiscal 2021 period due primarily to increased payroll related costs, non-cash equity compensation and medical insurance expense.

Net Interest Expense



Net interest expense for the six months ended March 26, 2022 decreased $1.8
million, or 5.9%, to $29.1 million from $30.9 million for the six months ended
March 27, 2021. In the prior year six-month period, we issued $500 million
aggregate principal amount of 4.125% senior notes due October 2030 and used the
proceeds to redeem all of our outstanding aggregate principal amount 6.125%
senior notes due 2023 with the remainder available for general corporate
purposes. As a result of our redemption of the 2023 Notes, we recognized
incremental interest expense in the prior year six-month period of approximately
$10.0 million. Partially offsetting the reduction from the prior year's
incremental interest expense was increased interest expense in the current year
quarter related to our issuance in April 2021 of $400 million aggregate
principal amount of 4.125% senior notes due April 2031.

Debt outstanding on March 26, 2022 was $1,185.8 million compared to $979.0 million as of March 27, 2021. Our average borrowing rate for the six months ended March 26, 2022 decreased to 4.5% from 4.6% for the six months ended March 27, 2021.


                                       27
--------------------------------------------------------------------------------

Other Income (Expense)



Other income (expense) was an expense of $0.6 million for the six-month period
ended March 26, 2022 compared to income of $1.5 million for the six-month period
ended March 27, 2021, due primarily to foreign currency losses in the current
six-month period as compared to gains in the prior six-month period.

Income Taxes



Our effective income tax rate was 23.1% for the six-month period ended March 26,
2022 compared to 22.5% for the six-month period ended March 27, 2021. The
increase in our effective income tax rate was due primarily to increased foreign
earnings in higher tax rate jurisdictions.

Net Income and Earnings Per Share



Our net income for the six months ended March 26, 2022 was $78.7 million, or
$1.44 per diluted share, compared to $78.6 million, or $1.43 per diluted share,
for the six months ended March 27, 2021.


Use of Non-GAAP Financial Measures



We report our financial results in accordance with accounting principles
generally accepted in the United States (GAAP). However, to supplement the
financial results prepared in accordance with GAAP, we use non-GAAP financial
measures including non-GAAP net income and diluted net income per share,
adjusted EBITDA and organic sales. Management believes these non-GAAP financial
measures that exclude the impact of specific items (described below) may be
useful to investors in their assessment of our ongoing operating performance and
provide additional meaningful comparisons between current results and results in
prior operating periods.

Adjusted EBITDA is defined by us as income before income tax, net other expense,
net interest expense, depreciation and amortization and stock-based compensation
(or operating income plus depreciation and amortization and stock-based
compensation expense). We present adjusted EBITDA because we believe that
adjusted EBITDA is a useful supplemental measure in evaluating the cash flows
and performance of our business and provides greater transparency into our
results of operations. Adjusted EBITDA is used by our management to perform such
evaluation. Adjusted EBITDA should not be considered in isolation or as a
substitute for cash flow from operations, income from operations or other income
statement measures prepared in accordance with GAAP. We believe that adjusted
EBITDA is frequently used by investors, securities analysts and other interested
parties in their evaluation of companies, many of which present adjusted EBITDA
when reporting their results. Other companies may calculate adjusted EBITDA
differently and it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.



The reconciliations of these non-GAAP measures to the most directly comparable
financial measures calculated and presented in accordance with GAAP are shown in
the tables below. We believe that the non-GAAP financial measures provide useful
information to investors and other users of our financial statements by allowing
for greater transparency in the review of our financial and operating
performance. Management also uses these non-GAAP financial measures in making
financial, operating and planning decisions and in evaluating our performance,
and we believe these measures similarly may be useful to investors in evaluating
our financial and operating performance and the trends in our business from
management's point of view. While our management believes that non-GAAP
measurements are useful supplemental information, such adjusted results are not
intended to replace our GAAP financial results and should be read in conjunction
with those GAAP results.


Non-GAAP financial measures reflect adjustments based on the following items:



•Incremental expenses from note redemption and issuance: we have excluded the
impact of the incremental expenses incurred from the note redemption and
issuance as they represent an infrequent transaction that occurs in limited
circumstances that impacts the comparability between operating periods. We
believe the adjustment of these expenses supplements the GAAP information with a
measure that may be used to assess the sustainability of our operating
performance.

•Loss on sale of business: we have excluded the impact of the loss on the sale
of a business as it represents an infrequent transaction that occurs in limited
circumstances that impacts the comparability between operating periods. We
believe the adjustment of this loss supplements the GAAP information with a
measure that may be used to assess the sustainability of our operating
performance.

                                       28
--------------------------------------------------------------------------------

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments reflect the following:



(1)During the first quarter of fiscal 2021, we issued $500 million aggregate
principal amount of 4.125% senior notes due October 2030. We used a portion of
the proceeds to redeem all of our outstanding 6.125% senior notes due 2023. As a
result of our redemption of the 2023 Notes, we incurred incremental expenses of
approximately $10.0 million, comprised of a call premium payment of $6.1
million, overlapping interest expense of approximately $1.4 million and a $2.5
million non-cash charge for the write-off of unamortized financing costs. These
amounts are included in Interest expense in the condensed consolidated
statements of operations.

(2)During the first quarter of fiscal 2021, we recognized a loss of $2.6 million, included in selling, general and administrative expense in the consolidated statement of operations, from the sale of our Breeder's Choice business unit after concluding it was not a strategic business for our Pet segment.

GAAP to Non-GAAP Reconciliation


                                                     For the Three Months Ended                       For the Six Months Ended
Net Income and Diluted Net Income Per
Share Reconciliation                          March 26, 2022

March 27, 2021 March 26, 2022 March 27, 2021


                                                                      (in thousands, except per share amounts)
GAAP net income attributable to
Central Garden & Pet Company                 $       69,713          $      

72,954 $ 78,722 $ 78,567 Incremental expenses from note redemption and issuance

               (1)                 -                        -                      -                    9,952
Loss on sale of business              (2)                 -                        -                      -                    2,611
Tax effect of incremental expenses,
loss on sale and impairment                  $            -          $             -                      -                   (2,821)
Non-GAAP net income attributable to
Central Garden & Pet Company                 $       69,713          $      

72,954 $ 78,722 $ 88,309 GAAP diluted net income per share

            $         1.27          $      

1.32 $ 1.44 $ 1.43 Non-GAAP diluted net income per share $ 1.27 $

          1.32          $        1.44          $          1.61
Shares used in GAAP and non-GAAP
diluted net earnings per share
calculation                                          54,722                   55,156                 54,818                   54,930


Organic Net Sales Reconciliation



We have provided organic net sales, a non-GAAP measure that excludes the impact
of recent acquisitions and dispositions, because we believe it permits investors
to better understand the performance of our historical business. We define
organic net sales as net sales from our historical business derived by excluding
the net sales from businesses acquired or exited in the preceding 12 months.
After an acquired business has been part of our consolidated results for 12
months, the change in net sales thereafter is considered part of the increase or
decrease in organic net sales.

Consolidated                                                                

GAAP to Non-GAAP Reconciliation


                                            For Three Months Ended March 26, 2022                               For the Six Months Ended March 26, 2022
                                                             Effect of                                                           Effect of
                                                           acquisition &                                                       acquisition &
                                                          divestitures on                                                     divestitures on
                                                          increase in net         Net sales                                   increase in net          Net sales
                                  Net sales (GAAP)             sales               organic            Net sales (GAAP)             sales                organic
                                                                                           (in millions)
Q2 FY 22                         $        954.4           $       51.8          $    902.6           $      1,615.8           $       121.8          $  1,494.0
Q2 FY 21                                  935.3                      -               935.3                  1,527.5                     3.9             1,523.6
$ increase (decrease)            $         19.1                                 $    (32.7)          $         88.3                                  $    (29.6)
% increase (decrease)                       2.0   %                                   (3.5) %                   5.8   %                                    (1.9) %


                                       29

--------------------------------------------------------------------------------

Pet                                                                      

GAAP to Non-GAAP Reconciliation


                                      For Three Months Ended March 26, 2022                             For the Six Months Ended March 26, 2022
                                                      Effect of                                                      Effect of
                                                    acquisition &                                                    acquisition &
                                                   divestitures on                                                   divestitures on
                                                   increase in net          Net sales          Net sales             increase in net         Net sales
                           Net sales (GAAP)             sales                organic           (GAAP)                sales                    organic
                                                                                  (in millions)
Q2 FY 22                  $        497.7           $           -          $    497.7           $    933.7            $          -          $    933.7
Q2 FY 21                           492.0                       -               492.0                928.4                     3.9               924.5
$ increase                $          5.7                                  $      5.7           $      5.3                                  $      9.2
% increase                           1.2   %                                     1.2  %               0.6    %                                    1.0  %


Garden                                                                     

GAAP to Non-GAAP Reconciliation


                                            For Three Months Ended March 26, 2022                               For the Six Months Ended March 26, 2022
                                                             Effect of                                                        Effect of
                                                           acquisition &                                                      acquisition &
                                                          divestitures on                                                     divestitures on
                                                          increase in net         Net sales                                   increase in net          Net sales
                                  Net sales (GAAP)             sales               organic           Net sales (GAAP)         sales                     organic
                                                                                           (in millions)
Q2 FY 22                         $        456.7           $       51.8          $    404.9           $        682.1           $       121.8          $    560.3
Q2 FY 21                                  443.3                      -               443.3                    599.1                       -               599.1
$ increase (decrease)            $         13.4                                 $    (38.4)          $         83.0                                  $    (38.8)
% increase (decrease)                       3.0   %                                   (8.7) %                  13.9   %                                    (6.5) %



Adjusted EBITDA Reconciliation                                      GAAP to 

Non-GAAP Reconciliation


                                                               For the 

Three Months Ended March 26, 2022


                                                     Garden               Pet               Corp              Total
                                                                             (in thousands)
Net income attributable to Central Garden
& Pet Company                                    $         -          $      -          $       -          $  69,713
   Interest expense, net                                   -                 -                  -             14,702
   Other expense                                           -                 -                  -                369
   Income tax expense                                      -                 -                  -             21,488
   Net income attributable to
noncontrolling interest                                    -                 -                  -                573

     Sum of items below operating income                   -               

 -                  -             37,132
Income (loss) from operations                    $    70,511          $ 60,645          $ (24,311)         $ 106,845
Depreciation & amortization                            7,719             9,539                989             18,247
Noncash stock-based compensation                           -                 -              6,292              6,292
Adjusted EBITDA                                  $    78,230          $ 70,184          $ (17,030)         $ 131,384


                                       30

--------------------------------------------------------------------------------

                                                                    GAAP to Non-GAAP Reconciliation
Adjusted EBITDA Reconciliation                                 For the 

Three Months Ended March 27, 2021


                                                     Garden               Pet               Corp              Total
                                                                             (in thousands)
Net income attributable to Central Garden
& Pet Company                                    $         -          $      -          $       -          $  72,954
   Interest expense, net                                      -                 -                  -          10,151
   Other income                                               -                 -                  -            (704)
   Income tax expense                                         -                 -                  -          21,564
   Net income attributable to
noncontrolling interest                                       -                 -                  -             645

     Sum of items below operating income                      -            

    -                  -          31,656
Income (loss) from operations                    $    65,962          $ 62,058          $ (23,410)         $ 104,610
Depreciation & amortization                            8,804             8,882              1,168             18,854
Noncash stock-based compensation                           -                 -              5,725              5,725
Adjusted EBITDA                                  $    74,766          $ 70,940          $ (16,517)         $ 129,189


Adjusted EBITDA Reconciliation                                        GAAP 

to Non-GAAP Reconciliation


                                                                  For the 

Six Months Ended March 26, 2022


                                                      Garden                Pet                Corp              Total
                                                                              (in thousands)
Net income attributable to Central Garden
& Pet Company                                    $        -             $       -          $       -          $  78,722
   Interest expense, net                                  -                     -                  -             29,110
   Other expense                                          -                     -                  -                578
   Income tax expense                                     -                     -                  -             23,889
   Net income attributable to
noncontrolling interest                                   -                     -                  -                760

     Sum of items below operating income                  -                

    -                  -             54,337
Income (loss) from operations                    $   76,568             $ 105,896          $ (49,405)         $ 133,059
Depreciation & amortization                          17,339                19,088              2,022             38,449
Noncash stock-based compensation                          -                     -             11,479             11,479
Adjusted EBITDA                                  $   93,907             $ 124,984          $ (35,904)         $ 182,987


                                                                      GAAP to Non-GAAP Reconciliation
Adjusted EBITDA Reconciliation                                    For the 

Six Months Ended March 27, 2021


                                                      Garden                Pet                Corp              Total
                                                                              (in thousands)
Net income attributable to Central Garden
& Pet Company                                    $        -             $       -          $       -          $  78,567
   Interest expense, net                                  -                     -                  -             30,920
   Other income                                           -                     -                  -             (1,456)
   Income tax expense                                     -                     -                  -             22,945
   Net income attributable to
noncontrolling interest                                   -                     -                  -                674

     Sum of items below operating income                  -                

    -                  -             53,083
Income (loss) from operations                    $   70,613             $ 105,583          $ (44,546)         $ 131,650
Depreciation & amortization                          11,442                17,967              2,360             31,769
Noncash stock-based compensation                          -                     -             10,394             10,394
Adjusted EBITDA                                  $   82,055             $ 123,550          $ (31,792)         $ 173,813


                                       31

--------------------------------------------------------------------------------

Inflation



Our revenues and margins are dependent on various economic factors, including
rates of inflation, energy costs, currency fluctuations, and other
macro-economic factors which may impact levels of consumer spending. In certain
fiscal periods, we have been adversely impacted by rising input costs related to
inflation, particularly relating to grain and seed prices, fuel prices and the
ingredients used in our garden controls and fertilizers. Rising costs in those
periods have made it difficult for us to increase prices to our retail customers
at a pace sufficient to enable us to maintain margins.

In fiscal 2022, we have continued to experience increasing inflationary pressure stemming in part from the COVID-19 operating environment, including notable increases in costs for key commodities, labor and freight.

Weather and Seasonality



Our sales of lawn and garden products are influenced by weather and climate
conditions in the different markets we serve. Our Garden segment's business is
highly seasonal. In fiscal 2021, approximately 69% of our Garden segment's net
sales and 60% of our total net sales occurred during our second and third fiscal
quarters. Substantially all of the Garden segment's operating income is
typically generated in this period, which has historically more than offset the
operating loss incurred during the first fiscal quarter of the year.

Liquidity and Capital Resources



We have financed our growth through a combination of internally generated funds,
bank borrowings, supplier credit, and sales of equity and debt securities to the
public.

Our business is seasonal and our working capital requirements and capital
resources track closely to this seasonal pattern. Generally, during the first
fiscal quarter, accounts receivable reach their lowest level while inventory,
accounts payable and short-term borrowings begin to increase. During the second
fiscal quarter, receivables, accounts payable and short-term borrowings
increase, reflecting the build-up of inventory and related payables in
anticipation of the peak lawn and garden selling season. During the third fiscal
quarter, inventory levels remain relatively constant while accounts receivable
peak and short-term borrowings start to decline as cash collections are received
during the peak selling season. During the fourth fiscal quarter, inventory
levels are at their lowest, and accounts receivable and payables are
substantially reduced through conversion of receivables to cash.

We service two broad markets: pet supplies and lawn and garden supplies. Our pet
supplies businesses involve products that have a year round selling cycle with a
slight degree of seasonality. As a result, it is not necessary to maintain large
quantities of inventory to meet peak demands. Our lawn and garden businesses are
highly seasonal with approximately 69% of our Garden segment's net sales
occurring during the second and third fiscal quarters. This seasonality requires
the shipment of large quantities of product well ahead of the peak consumer
buying periods. To encourage retailers and distributors to stock large
quantities of inventory, industry practice has been for manufacturers to give
extended credit terms and/or promotional discounts.

Operating Activities



Net cash used by operating activities increased by $151.9 million, from $120.2
million for the six months ended March 27, 2021, to $272.1 million for the six
months ended March 26, 2022. The increase in cash used by operating activities
was due primarily to changes in our working capital accounts for the period
ended March 26, 2022, as compared to the prior year period, predominantly an
increase in inventory resulting from an intentional build-up in inventory due to
the increased demand for our products amid the continuing global supply chain
issues, as well as increased input costs.

Investing Activities



Net cash used in investing activities decreased $688.2 million, from $765.4
million for the six months ended March 27, 2021 to $77.2 million during the six
months ended March 26, 2022. The decrease in cash used in investing activities
was due primarily to the three acquisitions in the prior six-month period,
partially offset by an increase in capital expenditures of $41.8 million in the
current year compared to the prior year. During the first quarter of fiscal
2021, we acquired DoMyOwn for approximately $81 million. During the second
quarter of fiscal 2021, we acquired Hopewell Nursery on December 31, 2020 for
approximately $81 million and Green Garden Products on February 11, 2021 for
approximately $571 million.
                                       32
--------------------------------------------------------------------------------

Financing Activities



Net cash used by financing activities increased $293.5 million, from $270.5
million of cash provided for the six months ended March 27, 2021, to $23.0
million of cash used for the six months ended March 26, 2022. The increase in
cash used by financing activities during the current year was due primarily to
the issuance of $500 million of our 2030 Notes in October 2020 and net
borrowings under our senior secured credit facility of $190 million in the prior
year period, partially offset by the repayment of our 2023 Notes and the
corresponding premium paid on extinguishment in November 2020, as well as debt
issuance costs incurred on the issuance of the 2030 Notes. We also recommenced
open market purchases of our common stock during the current year period. During
the six months ended March 26, 2022, we repurchased approximately 0.4 million
shares of our non-voting Class A common stock (CENTA) on the open market at an
aggregate cost of approximately $16.1 million, or approximately $42.30 per
share. During the six months ended March 27, 2021, we did not make any open
market purchases of our common stock.

We expect that our principal sources of funds will be cash generated from our
operations and, if necessary, borrowings under our $750 million Amended Credit
Facility. Based on our anticipated cash needs, availability under our asset
backed revolving credit facility and the scheduled maturity of our debt, we
believe that our sources of liquidity should be adequate to meet our working
capital, capital spending and other cash needs for at least the next 12 months.
However, we cannot assure you that these sources will continue to provide us
with sufficient liquidity and, should we require it, that we will be able to
obtain financing on terms satisfactory to us, or at all.

We believe that cash flows from operating activities, funds available under our
asset backed loan facility, and arrangements with suppliers will be adequate to
fund our presently anticipated working capital and capital expenditure
requirements for the foreseeable future. We anticipate that our capital
expenditures, which are related primarily to replacements and expansion of and
upgrades to plant and equipment and also investment in our continued
implementation of a scalable enterprise-wide information technology platform,
will be approximately $115 million to $125 million in fiscal 2022, of which we
have invested approximately $75 million through March 26, 2022.

As part of our growth strategy, we have acquired a number of companies in the
past, and we anticipate that we will continue to evaluate potential acquisition
candidates in the future. If one or more potential acquisition opportunities,
including those that would be material, become available in the near future, we
may require additional external capital. In addition, such acquisitions would
subject us to the general risks associated with acquiring companies,
particularly if the acquisitions are relatively large.

Total Debt

At March 26, 2022, our total debt outstanding was $1,185.8 million, as compared with $979.0 million at March 27, 2021.

Senior Notes

Issuance of $400 million 4.125% Senior Notes due 2031

In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031 (the "2031 Notes"). We used the net proceeds from the offering to repay all outstanding borrowings under our Amended Credit Facility, with the remainder to be used for general corporate purposes.



We incurred approximately $6 million of debt issuance costs in conjunction with
this issuance, which included underwriter fees and legal, accounting and rating
agency expenses. The debt issuance costs are being amortized over the term of
the 2031 Notes.

The 2031 Notes require semi-annual interest payments on April 30 and October 30,
which commenced October 30, 2021. The 2031 Notes are unconditionally guaranteed
on a senior basis by each of our existing and future domestic restricted
subsidiaries which are borrowers under or guarantors of our Amended Credit
Facility. The 2031 Notes were issued in a private placement under Rule 144A and
will not be registered under the Securities Act of 1933.

We may redeem some or all of the 2031 Notes at any time, at our option, prior to
April 30, 2026 at the principal amount plus a "make whole" premium. At any time
prior to April 30, 2024, we may also redeem, at our option, up to 40% of the
notes with the proceeds of certain equity offerings at a redemption price of
104.125% of the principal amount of the notes. We may redeem some or all of the
2031 Notes at our option, at any time on or after April 30, 2026 for 102.063%,
on or after April 30, 2027 for 101.375%, on or after April 30, 2028 for 100.688%
and on or after April 30, 2029 for 100.0%, plus accrued and unpaid interest.

The holders of the 2031 Notes have the right to require us to repurchase all or
a portion of the 2031 Notes at a purchase price equal to 101% of the principal
amount of the notes repurchased, plus accrued and unpaid interest, upon the
occurrence of specific kinds of changes of control.

The 2031 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of March 26, 2022.


                                       33
--------------------------------------------------------------------------------

Issuance of $500 million 4.125% Senior Notes due 2030



In October 2020, we issued $500 million aggregate principal amount of 4.125%
senior notes due October 2030 (the "2030 Notes"). In November 2020, we used a
portion of the net proceeds to redeem all of our outstanding 6.125% senior notes
due November 2023 (the "2023 Notes") at a redemption price of 101.531% plus
accrued and unpaid interest, and to pay related fees and expenses, with the
remainder for general corporate purposes.

We incurred approximately $8.0 million of debt issuance costs associated with
this transaction, which included underwriter fees and legal, accounting and
rating agency expenses. The debt issuance costs are being amortized over the
term of the 2030 Notes.

As a result of our redemption of the 2023 Notes, we incurred a call premium
payment of $6.1 million, overlapping interest expense for 30 days of
approximately $1.4 million and a $2.5 million non-cash charge for the write-off
of unamortized deferred financing costs related to the 2023 Notes. These amounts
are included in interest expense in the condensed consolidated statements of
operations.

The 2030 Notes require semiannual interest payments on October 15 and April 15.
The 2030 Notes are unconditionally guaranteed on a senior basis by each of our
existing and future domestic restricted subsidiaries which are borrowers under
or guarantors of our senior secured revolving credit facility or guarantee our
other debt.

We may redeem some or all of the 2030 Notes at any time, at our option, prior to
October 15, 2025 at a price equal to 100% of the principal amount plus a
"make-whole" premium. Prior to October 15, 2023, we may redeem up to 40% of the
original aggregate principal amount of the notes with the proceeds of certain
equity offerings at a redemption price of 104.125% of the principal amount of
the notes. We may redeem some or all of the 2030 Notes, at our option, in whole
or in part, at any time on or after October 15, 2025 for 102.063%, on or after
October 15, 2026 for 101.375%, on or after October 15, 2027 for 100.688% and on
or after October 15, 2028 for 100.0%, plus accrued and unpaid interest.

The holders of the 2030 Notes have the right to require us to repurchase all or
a portion of the 2030 Notes at a purchase price equal to 101.0% of the principal
amount of the notes repurchased, plus accrued and unpaid interest upon the
occurrence of a change of control.

The 2030 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of March 26, 2022.

$300 Million 5.125% Senior Notes due 2028



In December 2017, we issued $300 million aggregate principal amount of 5.125%
senior notes due February 2028 (the "2028 Notes"). We used the net proceeds from
the offering to finance acquisitions and for general corporate purposes.

We incurred approximately $4.8 million of debt issuance costs in conjunction
with this transaction, which included underwriter fees and legal, accounting and
rating agency expenses. The debt issuance costs are being amortized over the
term of the 2028 Notes.

The 2028 Notes require semiannual interest payments on February 1 and August 1.
The 2028 Notes are unconditionally guaranteed on a senior basis by our existing
and future domestic restricted subsidiaries who are borrowers under or
guarantors of our senior secured revolving credit facility or who guarantee the
2030 Notes.

We may redeem some or all of the 2028 Notes at any time, at our option, prior to
January 1, 2023 at the principal amount plus a "make whole" premium. We may
redeem some or all of the 2028 Notes, at our option, at any time on or after
January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or
after January 1, 2025 for 100.854% and on or after January 1, 2026 for 100.0%,
plus accrued and unpaid interest.

The holders of the 2028 Notes have the right to require us to repurchase all or
a portion of the 2028 Notes at a purchase price equal to 101% of the principal
amount of the notes repurchased, plus accrued and unpaid interest upon the
occurrence of a change of control.

The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of March 26, 2022.


                                       34
--------------------------------------------------------------------------------

Asset-Based Loan Facility Amendment



On December 16, 2021, we entered into a Third Amended and Restated Credit
Agreement ("Amended Credit Agreement"). The Amended Credit Agreement amended and
restated the previous credit agreement dated September 27, 2019 (the
"Predecessor Credit Agreement"), and has been increased to provide for a $750
million principal amount senior secured asset-based revolving credit facility,
with up to an additional $400 million principal amount available with the
consent of the Lenders, as defined, if we exercise the uncommitted accordion
feature set forth therein (collectively, the "Amended Credit Facility"). The
Amended Credit Facility matures on December 16, 2026. We may borrow, repay and
reborrow amounts under the Amended Credit Facility until its maturity date, at
which time all amounts outstanding under the Amended Credit Facility must be
repaid in full.

The Amended Credit Facility is subject to a borrowing base that is calculated
using a formula based upon eligible receivables and inventory, and at our
election, eligible real property, minus certain reserves. We did not draw down
any commitments under the Amended Credit Facility upon closing. Proceeds of the
Amended Credit Facility will be used for general corporate purposes. Net
availability under the Amended Credit Facility was approximately $652 million as
of March 26, 2022. The Amended Credit Facility includes a $50 million sublimit
for the issuance of standby letters of credit and a $75 million sublimit for
short-notice borrowings. As of March 26, 2022, there were no borrowings
outstanding and no letters of credit outstanding under the Amended Credit
Facility. There were other letters of credit of $1.3 million outstanding as of
March 26, 2022.

Borrowings under the Amended Credit Facility will bear interest at an index
based on LIBOR (which will not be less than 0.00%) or, at our option, the Base
Rate, plus, in either case, an applicable margin based on our usage under the
credit facility. Base Rate is defined as the highest of (a) the Truist prime
rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month LIBOR plus 1.00% and
(d) 0.00%. The applicable margin for LIBOR-based borrowings fluctuates between
1.00%-1.50%, and was 1.00% as of March 26, 2022, and such applicable margin for
Base Rate borrowings fluctuates between 0.00%-0.50%, and was 0% as of March 26,
2022. An unused line fee shall be payable quarterly in respect of the total
amount of the unutilized Lenders' commitments and short-notice borrowings under
the Amended Credit Facility. Letter of credit fees at the applicable margin on
the average undrawn and unreimbursed amount of letters of credit shall be
payable quarterly and a facing fee of 0.125% shall be payable quarterly for the
stated amount of each letter of credit. We are also required to pay certain fees
to the administrative agent under the Amended Credit Facility. The Amended
Credit Facility provides for the transition from LIBOR to SOFR and does not
require an amendment in connection with such transition. As of March 26, 2022,
the applicable interest rate related to Base Rate borrowings was 3.3%, and the
applicable interest rate related to one-month LIBOR-based borrowings was 1.4%.

We incurred approximately $2.4 million of debt issuance costs in conjunction
with this transaction, which included lender fees and legal expenses. The debt
issuance costs are being amortized over the term of the Amended Credit Facility.

The Amended Credit Facility continues to contain customary covenants, including
financial covenants which require us to maintain a minimum fixed charge coverage
ratio of 1:1 upon triggered quarterly testing (e.g. when availability falls
below certain thresholds established in the agreement), reporting requirements
and events of default. The Amended Credit Facility is secured by substantially
all assets of the borrowing parties, including (i) pledges of 100% of the stock
or other equity interest of each domestic subsidiary that is directly owned by
such entity and (ii) 65% of the stock or other equity interest of each foreign
subsidiary that is directly owned by such entity, in each case subject to
customary exceptions. We were in compliance with all financial covenants under
the Amended Credit Facility during the period ended March 26, 2022.

Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities



Central (the "Parent/Issuer") issued $400 million of 2031 Notes in April 2021,
$500 million of 2030 Notes in October 2020, and $300 million of 2028 Notes in
December 2017. The 2031 Notes, 2030 Notes and 2028 Notes are fully and
unconditionally guaranteed on a joint and several senior basis by each of our
existing and future domestic restricted subsidiaries (the "Guarantors") which
are guarantors of our senior secured revolving credit facility ("Credit
Facility"). The 2031 Notes, 2030 Notes and 2028 Notes are unsecured senior
obligations and are subordinated to all of our existing and future secured debt,
including our Amended Credit Facility, to the extent of the value of the
collateral securing such indebtedness. There are no significant restrictions on
the ability of the Guarantors to make distributions to the Parent/Issuer.
Certain subsidiaries and operating divisions of the Company do not guarantee the
2031, 2030 or 2028 Notes and are referred to as the Non-Guarantors.

The Guarantors jointly and severally, and fully and unconditionally, guarantee
the payment of the principal and premium, if any, and interest on the 2031, 2030
and 2028 Notes when due, whether at stated maturity of the 2031, 2030 and 2028
Notes, by acceleration, call for redemption or otherwise, and all other
obligations of the Company to the holders of the 2031, 2030 and 2028 Notes and
to the trustee under the indenture governing the 2031, 2030 and 2028 Notes (the
"Guarantee"). The Guarantees are senior unsecured obligations of each Guarantor
and are of equal rank with all other existing and future senior indebtedness of
the Guarantors.

The obligations of each Guarantor under its Guarantee shall be limited to the
maximum amount as well, after giving effect to all other contingent and fixed
liabilities of such Guarantor and to any collections from or payments made by or
on behalf of any other Guarantor in

                                       35
--------------------------------------------------------------------------------

respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under Federal or state law.

The Guarantee of a Guarantor will be released:



(1) upon any sale or other disposition of all or substantially all of the assets
of that Guarantor (including by way of merger or consolidation), in accordance
with the governing indentures, to any person other than the Company;

(2) if such Guarantor merges with and into the Company, with the Company surviving such merger;

(3) if the Guarantor is designated as an Unrestricted Subsidiary; or



(4) if the Company exercises its legal defeasance option or covenant defeasance
option or the discharge of the Company's obligations under the indentures in
accordance with the terms of the indentures.

The following tables present summarized financial information of the
Parent/Issuer subsidiaries and the Guarantor subsidiaries. All intercompany
balances and transactions between subsidiaries under Parent/Issuer and
subsidiaries under the Guarantor have been eliminated. The information presented
below excludes eliminations necessary to arrive at the information on a
consolidated basis. In presenting the summarized financial statements, the
equity method of accounting has been applied to the Parent/Issuer's interests in
the Guarantor Subsidiaries. The summarized information excludes financial
information of the Non-Guarantors, including earnings from and investments in
these entities.


Summarized Statements of
Operations
                                              Six Months Ended                            Fiscal Year Ended
                                               March 26, 2022                             September 25, 2021
                                     Parent/Issuer           Guarantors           Parent/Issuer           Guarantors
                                                                     (in thousands)
Net sales                          $      420,651          $ 1,102,518          $      908,599          $ 2,142,925
Gross profit                       $       97,911          $   360,871          $      205,837          $   686,332
Income (loss) from operations      $        1,069          $   135,416          $        4,382          $   229,961
Equity in earnings of Guarantor    $      104,201          $         -          $      183,122          $         -
subsidiaries
Net income (loss)                  $      (21,444)         $   104,201

$ (45,596) $ 183,122

© Edgar Online, source Glimpses